Form 13-F position report

INVO BIOSCIENCE INC COM STK (N

Reported by FRONTIER INVESTMENT MGMT CO

Company profile Manager portfolio Source filing
IVOB CUSIP 44984F104 Manager CIK 0001316539
Latest reported change

Reported 0 shares, down 20,200 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q3 2016
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 5 Through Q3 2016

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Manager history

Quarterly position history

How this manager's reported quarter-end position changed over time.

5 quarters
Quarter Activity Shares Change % of reported 13F Reported value Filed
Q3 2016 Reduced 0 -20,200 (-100.0%) 0 $0 2016-11-08
Q2 2016 Unchanged 20,200 0 (0.0%) < 0.01% $8,000 2016-08-12
Q1 2016 Reduced 20,200 -29,900 (-59.7%) < 0.01% $7,000 2016-05-13
Q4 2015 Added 50,100 +100 (0.2%) < 0.01% $35,000 2016-02-11
Q3 2015 New 50,000 +50,000 (0.0%) < 0.01% $23,000 2015-11-16
Institutional context

Who else reported the position

2 managers reported INVO BIOSCIENCE INC COM STK (N for Q3 2016.

Manager Activity Shares Change % of reported 13F Reported value Tenure
TWIN FOCUS CAPITAL PARTNERS LLC New 150,000 +150,000 0.03% $50,000 1 qtr
FRONTIER INVESTMENT MGMT CO This report Reduced 0 -20,200 0 $0 5 qtrs
A free account expands this comparison to 25 managers. Create free account
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2016
Filed
November 08, 2016
Filing type
13F-HR
Position type
COM

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.